RMED Insider Trading Activity and SEC Form 4 Filings
RMED insider trading summary
No open-market insider purchases or sales of Ra Medical Systems, Inc. (RMED) have been reported on SEC Form 4 in the past 12 months.
Latest RMED insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 22, 2021 | Jonathan Will McGuire | Chief Executive Officer | Sell | $21K (8,149 @ $2.62) |
| Nov 22, 2021 | Andrew C. Jackson | CFO | Sell | $7K (2,684 @ $2.62) |
| Nov 19, 2020 | Martin J Colombatto | Director | Buy | $50K (8,700 @ $5.78) |
| Nov 19, 2020 | William R Enquist | Director | Buy | $31K (5,263 @ $5.82) |
| Nov 19, 2020 | Richard Mejia Jr | Director | Buy | $6K (1,000 @ $5.82) |
| Nov 19, 2020 | Joan Stafslien | Director | Buy | $25K (4,410 @ $5.67) |
| Aug 3, 2020 | Jonathan Will McGuire | Chief Executive Officer | Buy | $4K (10,000 @ $0.35) |
| Aug 3, 2020 | Andrew C. Jackson | CFO | Buy | $4K (10,000 @ $0.35) |
| Aug 3, 2020 | Daniel Horwood | General Counsel | Buy | $4K (10,000 @ $0.35) |
| Aug 3, 2020 | Jeffrey J Kraws | Co-President | Buy | $4K (10,000 @ $0.35) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.